Preventive chemotherapy in human helminthiasis: Theoretical and operational aspects

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 12, 2011, Pages 683-693

  Gabrielli, A F ^a   Montresor, A ^a   Chitsulo, L ^a   Engels, D ^a   Savioli, L ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Disease control; Helminth infection; Preventive chemotherapy

Indexed keywords

ANTHELMINTIC AGENT;

ARTICLE; DISEASE TRANSMISSION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FILARIASIS; HELMINTHIASIS; HUMAN; INFECTION CONTROL; LYMPHATIC FILARIASIS; MORBIDITY; NONHUMAN; ONCHOCERCIASIS; PARASITE PREVALENCE; SCHISTOSOMIASIS; TREATMENT OUTCOME;

ANIMALS; ANTHELMINTICS; COST-BENEFIT ANALYSIS; ELEPHANTIASIS, FILARIAL; FEMALE; HELMINTHIASIS; HUMANS; MALE; ONCHOCERCIASIS; PATIENT SELECTION; PUBLIC HEALTH; RISK FACTORS; SCHISTOSOMIASIS; SOIL;

VERMES;

EID: 81055156583     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.08.013     Document Type: Article

References (62)

1. WHO Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers 2006, World Health Organization, Geneva.
2. WHO Neglected tropical diseases. PCT databank 2011, World Health Organization, Geneva.
3. Fenwick A. Host-parasite relations and implications for control. Adv Parasitol 2009, 68:247-261.
4. de Carneri I. Parassitologia Generale e Umana 1961, Casa Editrice Ambrosiana, Milan. 1st ed.
5. Crompton D.W., Savioli L. Handbook of helminthiasis for public health 2006, CRC Press, Boca Raton, FL.
6. Anderson R.M., May R.M. Infectious diseases of humans: dynamics and control 1991, Oxford University Press, New York, NY.
7. WHO Report of the WHO Informal Consultation on the use of chemotherapy for the control of morbidity due to soil-transmitted nematodes in humans 1996, World Health Organization, Geneva.
8. Warren K.S. The control of helminths: nonreplicating infectious agents of man. Annu Rev Public Health 1981, 2:101-105.
9. May R.M. Ecology and population biology. Tropical and geographical medicine 1990, 130-145. McGraw Hill Book Company, New York, NY. 2nd ed. K.S. Warren, A.A.F. Mahmoud (Eds.).
10. Hotez P.J. Stigma: the stealth weapon of the NTD. PLoS Negl Trop Dis 2008, 2:e230.
11. Molyneux D.H., Hopkins D.R., Zagaria N. Disease eradication, elimination and control: the need for accurate and consistent usage. Trends Parasitol 2004, 20:347-351.
12. Remme J., De Sole G., Dadzie K.Y., Alley E.S., Baker R.H., Habbema J.D., et al. Large scale ivermectin distribution and its epidemiological consequences. Acta Leiden 1990, 59:177-191.
13. Gyapong J.O., Kumaraswami V., Biswas G., Ottesen E.A. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2005, 6:179-200.
14. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118.
15. Albonico M., Montresor A., Crompton D.W.T., Savioli L. Intervention for the control of soil-transmitted helminthiasis in the community. Adv Parasitol 2006, 61:311-348.
16. Boatin B.A., Richards F.O. Control of onchocerciasis. Adv Parasitol 2006, 61:349-394.
17. Ottesen E.A. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 2006, 61:395-441.
18. Albonico M., Allen H., Chitsulo L., Engels D., Gabrielli A.F., Savioli L. Controlling soil-transmitted helminthiasis in pre-school-age children through preventive chemotherapy. PLoS Negl Trop Dis 2008, 2:e126.
19. Satayathum S.A., Muchiri E.M., Ouma J.H., Whalen C.C., King C.H. Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program. Am J Trop Med Hyg 2006, 75:83-92.
20. Keang H., Odermatt P., Odermatt-Biays S., Cheam S., Degremont A., Hatz C. Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration. Trans R Soc Trop Med Hyg 2007, 101:759-765.
21. Urbani C., Sinoun M., Socheat D., Pholsena K., Strandgaard H., Odermatt P., et al. Epidemiology and control of mekongi schistosomiasis. Acta Trop 2002, 82:157-168.
22. Dowdle W.R. The principles of disease elimination and eradication. Bull World Health Organ 1998, 76(Suppl 2):22-25.
23. Ferrari M.J., Bansal S., Meyers L.A., Bjornstad O.N. Network frailty and the geometry of herd immunity. Proc Biol Sci 2006, 273:2743-2748.
24. MacDonald G. The dynamics of helminth infections, with special reference to schistosomes. Trans R Soc Trop Med Hyg 1965, 59:489-506.
25. Ross R. Report on the prevention of malaria in Mauritius 1909, J. and A. Churchill, London.
26. Stolk W.A., de Vlas S.J., Habbema J.D. Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling. Filaria J 2006, 5:5.
27. WHO/GPELF Lymphatic filariasis. Monitoring and epidemiological assessment of mass drug administration. A manual for national elimination programmes 2011, World Health Organization, Geneva.
28. WHO Onchocerciasis and its control. Report of a WHO Expert Committee 1995, World Health Organization, Geneva.
29. WHO The schistosomiasis manual 1995, World Health Organization, Geneva.
30. WHO Helminth control in school-age children. A guide for managers of control programmes 2002, World Health Organization, Geneva.
31. WHO WHO model formulary 2008 2008, World Health Organization, Geneva.
32. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Sachs S.E., Sachs J.D., et al. Control of neglected tropical diseases. N Engl J Med 2007, 357:1018-1027.
33. Muller R. Worms and human diseases 2001, CABI Publishing, Wallingford. 2nd ed.
34. Cook G., Zumla A. Manson's tropical diseases 2003, Saunders Ltd., London. 21st ed.
35. Hopkins A.D. Ivermectin and onchocerciasis: is it all solved?. Eye (Lond) 2005, 19:1057-1066.
36. Lindblade K.A., Arana B., Zea-Flores G., Rizzo N., Porter C.H., Dominguez A., et al. Elimination of Onchocercia volvulus transmission in the Santa Rosa focus of Guatemala. Am J Trop Med Hyg 2007, 77:334-341.
37. Diawara L., Traoré M.O., Badji A., Bissan Y., Doumbia K., Goita S.F., et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 2009, 3:e497.
38. Ottesen E.A., Duke B.O., Karam M., Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503.
39. Onchocerciasis (river blindness). Report from the sixteenth InterAmerican Conference on Onchocerciasis, Antigua Guatemala, Guatemala. Wkly Epidemiol Rec 2007; 82:314-6.
40. Bockarie M.J., Molyneux D.H. The end of lymphatic filariasis?. BMJ 2009, 338:b1686.
41. WHO/GPELF Lymphatic filariasis. Progress Report 2000-2009 and Strategic Plan 2010-2020 2010, World Health Organization, Geneva.
42. Fenwick A., Rollinson D., Southgate V. Implementation of human schistosomiasis control: challenges and prospects. Adv Parasitol 2006, 61:567-622.
43. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006, 367:1521-1532.
44. de Silva N.R., Brooker S., Hotez P.J., Montresor A., Engels D., Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003, 19:547-551.
45. Hall A., Anwar K.S., Tomkins A.M. Intensity of reinfection with Ascaris lumbricoides and its implications for parasite control. Lancet 1992, 339:1253-1257.
46. French M.D., Churcher T.S., Gambhir M., Fenwick A., Webster J.P., Kabatereine N., et al. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl Trop Dis 2010, 4:e897.
47. Sinuon M., Tsuyuoka R., Socheat D., Odermatt P., Ohmae H., Matsuda H., et al. Control of Schistosoma mekongi in Cambodia: results of eight years of control activities in the two endemic provinces. Trans R Soc Trop Med Hyg 2007, 101:34-39.
48. Touré S., Zhang Y., Bosqué-Oliva E., Ky C., Ouedraogo A., Koukounari A., et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ 2008, 86:780-787. A.
49. Huyse T., Webster B.L., Geldof S., Stothard J.R., Diaw O.T., Polman K., et al. Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathog 2009, 5:e1000571.
50. Schantz P.M., Cruz M., Sarti E., Pawlowski Z. Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ 1993, 27:397-403.
51. Garcia H.H., Gilman R.H., Gonzalez A.E., Varastegui E. Epidemiology of Taenia solium infection in Peru. Taenia solium taeniosis/cysticercosis 1999, 297-306. Editorial Universo, Lima. H.H. Garcia, S. Martinez (Eds.).
52. Strickland G.T. Hunter's tropical medicine 1991, W.B. Saunders Co., Philadelphia, PA. 7th ed.
53. Schantz P.M. Taenia solium cysticercosis/taeniosis is a potentially eradicable disease: developing a strategy for action and obstacles to overcome. Taenia solium taeniosis/cysticercosis 1999, 215-218. Editorial Universo, Lima. H. Garcia, S. Martinez (Eds.).
54. Gonzalez A.E., Garcia H.H., Gilman R.H., Tsang V.C. Control of Taenia solium. Acta Trop 2003, 87:103-109. Cisticercosis Working Group in Peru.
55. Pawlowski Z.S. Role of chemotherapy of taeniasis in prevention of neurocysticercosis. Parasitol Int 2006, 55(Suppl):S105-S109.
56. Mas-Coma S., Bargues M.D., Esteban J.C. Human fascioliasis. Fascioliasis 1999, 411-434. CABI Publishing, Wallingford. J.P. Dalton (Ed.).
57. Savioli L., Chitsulo L., Montresor A. New opportunities for the control of fascioliasis. Bull World Health Organ 1999, 77:300.
58. Keiser J., Engels D., Buscher G., Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 2005, 14:1513-1526.
59. Curtale F., Hassanein Y.A., Savioli L. Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt. Trans R Soc Trop Med Hyg 2005, 99:599-609.
60. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005, 79:207-216.
61. Eberhard M., Gabrielli A.F., Savioli L. Strongyloidiasis. Control of communicable diseases manual 2008, 588-590. American Public Health Association, Washington, DC. D.L. Heymann (Ed.).
62. Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996, 55:477-481.